| Literature DB >> 24900427 |
Benjamin Maurer1, Tobias Rumpf1, Michael Scharfe2, Diana A Stolfa1, Martin L Schmitt1, Wenjuan He3, Eric Verdin3, Wolfgang Sippl2, Manfred Jung1.
Abstract
NAD(+)-dependent histone deacetylases (sirtuins) play important roles in epigenetic regulation but also through nonhistone substrates for other key cellular events and have been linked to the pathogenesis of cancer, neurodegeneration, and metabolic diseases. The subtype Sirt5 has been shown recently to act as a desuccinylating and demalonylating enzyme. We have established an assay for biochemical testing of Sirt5 using a small labeled succinylated lysine derivative. We present a comparative study on the profiling of several established sirtuin inhibitors on Sirt1-3 as well as Sirt5 and also present initial results on a screening for new compounds that block Sirt5. Thiobarbiturates were identified as new Sirt5 inhibitors in the low micromolar range, which are selective over Sirt3 that can be found in the same cell compartment as Sirt5.Entities:
Keywords: AMC assay; Sirt5; desuccinylation; sirtinol; sirtuin
Year: 2012 PMID: 24900427 PMCID: PMC4025838 DOI: 10.1021/ml3002709
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345